| Clinical advances of siRNA-based nanotherapeutics for cancer treatment D Hattab, AM Gazzali, A Bakhtiar Pharmaceutics 13 (7), 1009, 2021 | 71 | 2021 |
| Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: A 3-year observational study SY Tan, RA Khan, KE Khalid, CW Chong, A Bakhtiar Scientific Reports 12 (1), 3106, 2022 | 30 | 2022 |
| Antituberculosis targeted drug delivery as a potential future treatment approach MKN Mazlan, MHD Mohd Tazizi, R Ahmad, MAA Noh, A Bakhtiar, ... Antibiotics 10 (8), 908, 2021 | 29 | 2021 |
| Bioengineered siRNA-based nanoplatforms targeting molecular signaling pathways for the treatment of triple negative breast cancer: preclinical and clinical advancements D Hattab, A Bakhtiar Pharmaceutics 12 (10), 929, 2020 | 29 | 2020 |
| Knockdown of PLC-gamma-2 and calmodulin 1 genes sensitizes human cervical adenocarcinoma cells to doxorubicin and paclitaxel A Stanislaus, A Bakhtiar, D Salleh, S Tiash, T Fatemian, S Hossain, ... Cancer cell international 12, 1-8, 2012 | 23 | 2012 |
| Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment ME Karim, ST Haque, H Al-Busaidi, A Bakhtiar, KK Tha, MMB Holl, ... Archives of pharmacal research 45 (12), 865-893, 2022 | 19 | 2022 |
| Intracellular delivery of potential therapeutic genes: prospects in cancer gene therapy A Bakhtiar, M Sayyad, R Rosli, A Maruyama, E H Chowdhury Current Gene Therapy 14 (4), 247-257, 2014 | 19 | 2014 |
| PH-responsive strontium nanoparticles for targeted gene therapy against mammary carcinoma cells A Bakhtiar, EH Chowdhury Asian journal of pharmaceutical sciences 16 (2), 236-252, 2021 | 16 | 2021 |
| Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells A Bakhtiar, QX Liew, KY Ng, EH Chowdhury Journal of Pharmaceutical Investigation 52 (2), 243-257, 2022 | 15 | 2022 |
| Strontium sulfite: a new pH-responsive inorganic nanocarrier to deliver therapeutic siRNAs to cancer cells ME Karim, J Shetty, RA Islam, A Kaiser, A Bakhtiar, EH Chowdhury Pharmaceutics 11 (2), 89, 2019 | 14 | 2019 |
| Exploring the causal relationship between telomere biology and Alzheimer’s disease XY Kuan, NSA Fauzi, KY Ng, A Bakhtiar Molecular Neurobiology 60 (8), 4169-4183, 2023 | 13 | 2023 |
| In vivo evaluation of biodistribution and toxicity of pH-responsive strontium nanoparticles for gene delivery A Bakhtiar, AS Neah, KY Ng, EH Chowdhury Journal of Pharmaceutical Investigation, 1-13, 2022 | 10 | 2022 |
| Intracellular delivery of p53 and MAPK siRNA into breast cancer cells utilising barium salt nanoparticles EC Athirah Bakhtiar, Nur Izyani Kamaruzzaman, Iekhsan Othman Journal of breast cancer research and advancement 1 (1), 2017 | 9* | 2017 |
| Intracellular delivery of NF-κB small interfering RNA for modulating therapeutic activities of classical anti-cancer drugs in human cervical cancer cells A Stanislaus, AP Kunnath, S Tiash, T Fatemian, NI Kamaruzman, ... Drugs and Therapy Studies 3 (1), e7-e7, 2013 | 3 | 2013 |
| SARS-CoV-2 journey: From alpha variant to omicron and its sub-variants D Hattab, MFA Amer, ZM Al-Alami, A Bakhtiar Infection 52 (3), 767-786, 2024 | 2 | 2024 |
| Evaluation of potential drug–drug interactions with medical cannabis JJY Ho, C Goh, CSA Leong, KY Ng, A Bakhtiar Clinical and Translational Science 17 (5), e13812, 2024 | | 2024 |
| Acceptability of COVID-19 booster vaccine in malaysia: a cross-sectional study CMJ Khoo, EZQ Dea, LY Law, SST Wong, KY Ng, A Bakhtiar Scientific Reports 14 (1), 8421, 2024 | | 2024 |
| Current status in cellular-based therapies for prevention and treatment of COVID-19 D Hattab, MFA Amer, A Mohd Gazzali, LH Chuah, A Bakhtiar Critical Reviews in Clinical Laboratory Sciences 60 (5), 321-345, 2023 | | 2023 |
| Antituberculosis targeted drug delivery as a potential future treatment approach. NM Mohd Khairul, DMT Mohammad Hafizie, R Ahmad, ... | | 2021 |
| Knockdown of PLC-gamma-2 and calmodulin 1 genes sensitizes human cervical adenocarcinoma cells to doxorubicin and paclitaxel EH Chowdhury, T Akaike, S Hossain, T Fatemian, S Tiash, D Salleh, ... | | 2012 |
ezharul hoque chowdhurymonash university在 monash.edu 的电子邮件经过验证
ezharul hoque chowdhurymonash university在 monash.edu 的电子邮件经过验证
Iekhsan OthmanJeffrey Cheah school of Medicine and health Sciences在 monash.edu 的电子邮件经过验证